United States · FDA National Drug Code directory
Lidovyx
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72835-447_6e720151-c3e3-4f59-a996-f652ad87b5a8
- Product NDC
- 72835-447
- Form
- GEL
- Composition / generic term
- Lidocaine 4%
- Labeler
- V2 Pharma LLC
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20260625
- Source listing expiry
- 20271231
Source-listed ingredients
- LIDOCAINE HYDROCHLORIDE — 40 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 70 g in 1 BOTTLE, WITH APPLICATOR (72835-447-01) · 72835-447-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →